What Next for TETRALOGIC PHARMACEUTICALS CORP (OTCMKTS:TLOG) Stock After Increase in Shorted Shares?

October 13, 2018 - By mmahotstuff

The stock of TETRALOGIC PHARMACEUTICALS CORP (OTCMKTS:TLOG) registered an increase of 8.32% in short interest. TLOG’s total short interest was 110,700 shares in October as published by FINRA. Its up 8.32% from 102,200 shares, reported previously. With 19,100 shares average volume, it will take short sellers 6 days to cover their TLOG’s short positions.

The stock decreased 0.51% or $0.0001 during the last trading session, reaching $0.0196. About 13,292 shares traded or 23.46% up from the average. TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG) has 0.00% since October 13, 2017 and is . It has underperformed by 15.62% the S&P500.

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. The company has market cap of $479,515. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. It currently has negative earnings. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.